Frequency of discussing and documenting advance care planning in primary care: secondary analysis of a multicenter cross-sectional observational study by Hamano, Jun et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Frequency of discussing and documenting advance care
planning in primary care: secondary analysis of a multicenter
cross-sectional observational study
Citation for published version:
Hamano, J, Oishi, A, Morita, T & Kizawa, Y 2020, 'Frequency of discussing and documenting advance care
planning in primary care: secondary analysis of a multicenter cross-sectional observational study', BMC
palliative care, vol. 19, no. 1. https://doi.org/10.1186/s12904-020-00543-y
Digital Object Identifier (DOI):
10.1186/s12904-020-00543-y
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Peer reviewed version
Published In:
BMC palliative care
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 11. May. 2020
RESEARCH ARTICLE Open Access
Frequency of discussing and documenting
advance care planning in primary care:
secondary analysis of a multicenter cross-
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Abstract
Background: To improve the quality of advance care planning (ACP) in primary care, it is important to understand
the frequency of and topics involved in the ACP discussion between patients and their family physicians (FPs).
Methods: A secondary analysis of a previous multicenter cross-sectional observational study was performed. The
primary outcome of this analysis was the frequency of and topics involved in the ACP discussion between outpatients
and FPs. In March 2017, 22 family physicians at 17 clinics scheduled a day to assess outpatients and enrolled patients
older than 65 years who were recognized by FPs as having regular visits. We defined three ACP discussion topics: 1)
future decline in activities of daily living (ADL), 2) future inability to eat, and 3) surrogate decision makers. FPs assessed
whether they had ever discussed any ACP topics with each patient and their family members, and if they had
documented the results of these discussions in medical records before patients were enrolled in the present study. We
defined patients as being at risk of deteriorating and dying if they had at least 2 positive general indicators or at least 1
positive disease-specific indicator in the Japanese version of the Supportive and Palliative Care Indicators Tool.
Results: In total, 382 patients with a mean age of 77.4 ± 7.9 years were enrolled, and 63.1% were female. Seventy-nine
patients (20.7%) had discussed at least one ACP topic with their FPs. However, only 23 patients (6.0%) had discussed an
ACP topic with family members and their FPs, with the results being documented in their medical records. The topic of
future ADL decline was discussed and documented more often than the other two topics. Patients at risk of deteriorating
and dying discussed ACP topics significantly more often than those not at risk of deteriorating and dying (39.4% vs.
16.8%, p< 0.001).
Conclusion: FPs may discuss ACP with some of their patients, but may not often document the results of this discussion
in medical records. FPs need to be encouraged to discuss ACP with patients and family members and describe the
decisions reached in medical records.
Keywords: Advance care planning, Aged patients, End of life care, Family physician, Primary care outpatients, Supportive
and palliative care indicators tool
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Introduction
Advance care planning (ACP) is an important process for
sharing care preferences, discussing the goals of care, and
making care plans through discussions between patients
and health care providers [1, 2]. A recent study revealed
that appropriate ACP was beneficial for patients, their
families, and the health system because it increases auton-
omy, dignity, peace, and intimacy at the time of death,
lessens grieving and decreases the risk of mental health
issues for family members, and reduces health care costs
and the utilization of resources [3].
Previous studies indicated that early recognition of the
risk of a particular patient deteriorating and dying is diffi-
cult, which suggests that the opportunity for ACP discus-
sions needs to be provided at the right time from the
perspective of illness trajectories [4, 5]. Since illness trajec-
tories vary widely, the development of ACP that considers
an individual patient’s trajectory is important [5].
In the opinion of patients, families, and health care
professionals, the family physician (FP) is the key profes-
sional for the discussion of ACP [4, 6–9]. Previous stud-
ies investigated the attitude of FPs toward ACP and the
facilitators of or barriers to discussing ACP with FPs
[10]; limited information is currently available on fre-
quency of and topics involved in the ACP discussion
among patients, their family members, and FPs [11–17].
According to a previous mortality follow-back study, 34%
of 1072 patients with non-sudden death had discussed
ACP with their FPs [16]. That study focused on terminally
ill patients, and revealed that the most frequent topic of dis-
cussion was not adopting potential life-prolonging treat-
ments. Another cross-sectional study revealed that ACP
was discussed between 16.3% of outpatients and their FPs;
however, the topics under discussion were not investigated
[17]. In addition, a recent study based on hypothetical vi-
gnette scenarios showed that FPs were more likely to dis-
cuss ACP when patients had severe clinical manifestations
[10]. A better understanding of the frequency of and topics
involved in the ACP discussion as well as the characteristics
of patients who discuss ACP with their FPs may contribute
to improving ACP quality in the primary care setting.
Therefore, we herein performed a secondary analysis of
our previous multicenter observational study to investigate
the frequency of and topics involved in the ACP discus-
sion among outpatients, their family members, and FPs
involved in primary care. In addition, the frequency of the
ACP discussion was compared between patients who
were/were not at risk of deteriorating and dying, and the
relationships between FP background factors and the dis-
cussion of ACP were examined.
Methods
The present study involved a secondary analysis of our
previous multicenter cross-sectional observational study
in Japan. Our previous study focused on the prevalence and
characteristics of primary care outpatients at risk of deteri-
orating and dying [18]. Participating facilities and FPs were
collected by purposive sampling. Each participating clinic
provided ambulatory care for community residents and had
at least one FP. In March 2017, 17 clinics (22 FPs) sched-
uled a day to assess their outpatients in advance. Patients
who were older than 65 years and who were recognized by
FPs as having regular visits were enrolled. The present
study was approved by the Institutional Review Board of
the University of Tsukuba (No. 1089).
Advance care planning
ACP was defined according to a previous Delphi study that
indicated ACP as a process that supports adults of any age
or health status to understand and share their personal
values, life goals, and preferences regarding future medical
care [2]. We also defined three ACP discussion topics, and
developed ad hoc questionnaires based on a literature re-
view and discussion among the authors [1, 2, 11, 12, 14, 16,
17, 19, 20]. The three ACP discussion topics were as fol-
lows: 1) future decline in the activities of daily living
(ADL), 2) future inability to eat, and 3) surrogate decision
makers. We defined the frequency of the ACP discussion
as discussing any of these topics at least once among the
patient and FP before enrollment in the study. Even when
patients and FPs talked about multiple topics more than
once, it was considered to be one ACP discussion. In
addition, we defined an optimized ACP discussion as a
discussion held among the patient, family members, and
FP together with documentation of the results in medical
records. This definition of an optimized ACP discussion
was based on the international consensus definition of
ACP, namely, ACP involves a patient discussing the above-
mentioned goals and preferences with family members and
health care providers, followed by recording and reviewing
the patient’s preferences if appropriate [1].
Patients at risk of deteriorating and dying
We identified patients who were at risk of deteriorating
and dying using the Japanese version of the Supportive
and Palliative Care Indicators Tool (SPICT-JP), as previ-
ously reported [18]. The original Supportive and Pallia-
tive Care Indicators Tool (SPICT™) was developed to
identify patients whose health condition is deteriorating.
Details of the development of SPICT™ and SPICT-JP
have been described elsewhere [18, 21–25].
Data collection
FPs were asked whether they had ever discussed any of
the ACP topics (a patient’s future ADL decline, future
inability to eat, and surrogate decision makers) with each
patient and their family members before the patient was
enrolled in the present study based on the FP’s memory,
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and to confirm whether the discussion had been docu-
mented in medical records. FPs also assessed patients
according to the Palliative Performance Scale (PPS) [26],
and 6 general clinical indicators and 25 disease-specific
indicators in the SPICT-JP (Additional file 1). Further-
more, FPs recorded the demographic and clinical char-
acteristics of patients. We also investigated the
background factors of FPs, including sex, duration of
clinical practice after obtaining a medical license, experi-
ence with a palliative care unit, and participation in the
nationwide palliative care education program.
Statistical analysis
Descriptive statistics were calculated for each ACP discus-
sion topic. According to previous studies, we defined pa-
tients as being at risk of deteriorating and dying if they had
at least 2 positive general indicators or at least 1 positive
disease-specific indicator in the SPICT-JP [25]. The rela-
tionship between the discussion of ACP and a patient’s risk
of deteriorating and dying was examined. We also investi-
gated the relationship between the discussion of ACP and
patients with PPS ≤ 70. The characteristics of participants
were reported as proportions for categorical variables and
were analyzed by Pearson’s χ2 test or Fisher’s exact test,
while continuous variables were analyzed by the Student’s
t-test. To examine the relationship between FP background
factors and the discussion of ACP topics, we performed
univariate and multivariate logistic regression analyses to
calculate the odds ratio (OR) and 95% confidence interval
(95% CI). FPs were categorized into 2 groups based on the
duration of clinical practice (> 15 years or ≤ 15 years). Back-
ground factors of FPs that showed significance in univariate
analyses were employed as independent variables in multi-
variate analyses. SPSS-J software (version 24.0; IBM, Tokyo,
Japan) was used to conduct all analyses, and p < 0.05 was
considered to be significant.
Results
In total, 382 patients from 17 clinics (22 FPs) were in-
cluded. Their mean age was 77.4 ± 7.9 years, and 63.1%
were female. Most patients had PPS ≥ 80 (79.1%), and did
not use care services (81.4%). The main underlying diseases
were hypertension (31.9%), dementia/frailty (15.2%),
and cardiovascular disease, excluding hypertension
(9.2%) (Table 1).
Among the 22 participating physicians, 12 had trained
at a palliative care unit (54.5%) and 17 had participated
in the nationwide palliative care education program
(77.3%) [27, 28] (Additional file 2).
Frequency of the ACP discussion and topics
While 20.7% of patients had discussed at least one of the
ACP topics with their FPs, only 6.0% had participated in
an optimized ACP discussion (Table 2).
Table 1 Demographic and Clinical Characteristics of Patients
(n = 382)
n %
Age (mean ± standard deviation) 77.4 ± 7.9
Sex
Male 141 36.9
Female 241 63.1
Living situation
Living with family 298 78.0
Living alone 59 15.4
Care facility 8 2.1
Main underlying disease
Hypertension 122 31.9
Dementia/frailty 58 15.2
Cardiovascular disease (excluding hypertension) 38 9.9
Diabetes 30 7.9
Hyperlipidemia 19 5.0
Neurological disease 18 4.7
Cancer 14 3.7
Respiratory disease 13 3.4
Musculoskeletal disease 8 2.1
Mental disorder 6 1.6
Gastroesophageal reflux disease 6 1.6
Kidney disease 5 1.3
Liver disease 3 0.8
Others 42 11.0
Palliative performance scale
100 202 52.9
90 51 13.4
80 49 12.8
70 20 5.2
60 33 8.6
50 22 5.8
40 5 1.3
Current use of care services
No care service 311 81.4
One or more care services 71 18.6
Types of care services used (Multiple answers)a
Home visit nursing 11 2.9
Nursing care services 16 4.2
Home visit pharmacist 1 0.3
Day care service 54 14.1
Specialized palliative care service 2 0.5
aThe type of care service used involved multiple choice questions, and most
patients did not use the care services
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Patients with liver disease had never discussed any of
the ACP topics. On the other hand, one third of patients
with cancer and neurological diseases, and one fifth of
those with dementia/frailty had discussed at least one
topic (Additional file 3). Each of the three ACP topics was
discussed more frequently with patients (8.4–18.1%) than
with their family members (3.7–7.3%) (Table 2). The topic
of future ADL decline was discussed and documented
more often than the other two topics. In 56 out of 79 pa-
tients (70.9%) who had discussed an ACP topic, the dis-
cussion was documented in their medical records.
Distribution of indicators for deteriorating and dying
The distribution of general and specific indicators for de-
teriorating health based on the SPICT-JP is shown in
Table 3. The most frequent general indicator was “The pa-
tient or family asked for palliative care, treatment with-
drawal/limitation, or a focus on quality of life” (25.4%).
Based on our definition, 66 patients (17.3%) were identi-
fied as being at risk of deteriorating and dying.
Frequency of the ACP discussion and topics among
patients at risk of deteriorating and dying, and patients
with PPS ≤ 70
Table 2 shows the frequency of the ACP discussion and
discussion topics among patients at risk of deteriorating
and dying and patients with PPS ≤ 70. These patients
discussed any one of the ACP topics significantly more
often than those not at risk of deteriorating and dying
(39.4% vs. 16.8%, p < 0.001), and also had a significantly
higher frequency of an optimized ACP discussion (19.7%
vs. 3.2%, p < 0.001).
The topics of future ADL decline and surrogate deci-
sion makers were discussed significantly more often with
patients at risk of deteriorating and dying than with
those who were not at risk (28.8% vs. 15.8%, p = 0.013;
16.7% vs. 6.6%, p = 0.008); however, no significant
Table 3 Prevalence of patients at risk of deteriorating and
dying
n %
General clinical risk of deteriorating health (n = 382)
Two or more unplanned hospital admissions in the
past 6 months
1 0.3
Performance status is poor or deteriorating, with
limited reversibility
24 6.3
Dependent on others for care due to physical and/or
mental health issues
26 6.8
Significant weight loss over the past 3–6 months
and/or a low body mass index
18 4.7
Persistent symptoms despite optimal treatment of
the underlying condition(s)
16 4.2
The patient or family asked for palliative care, treatment
withdrawal/limitation, or a focus on quality of life
97 25.4
Disease-specific risk for the deterioration of the conditions
Cancer (n = 14)
Functional ability deteriorating due to progressive cancer 3 21.4
Too frail for cancer treatment or treatment for symptom
control
2 14.3
Dementia/frailty (n = 56)
Unable to dress, walk, or eat without help 12 21.4
Eating and drinking less; difficulty swallowing 9 16.1
Urinary and fecal incontinence 13 23.2
No longer able to communicate using verbal language;
little social interaction
23 41.1
Fractured femur; multiple falls 10 17.9
Recurrent febrile episodes or infections; aspiration
pneumonia
2 3.6
Neurological disease (n = 18)
Progressive deterioration of physical and/or cognitive
function despite optimal therapy
7 38.9
Speech problems with increasing difficulty communicating
and/or progressive difficulty swallowing
2 11.1
Recurrent aspiration pneumonia; breathless or respiratory
failure
1 5.6
Cardiovascular disease (n = 38)
NYHA Class III/IV heart failure or extensive, untreatable
coronary artery disease with breathlessness or chest
pain at rest or on minimal exertion
4 10.5
Severe, inoperable peripheral vascular disease 0 0.0
Respiratory disease (n = 13)
Severe chronic lung disease with breathlessness at
rest or on minimal exertion between exacerbations
2 15.4
Needs long-term oxygen therapy 1 7.7
Has needed ventilation for respiratory failure or ventilation
is contraindicated
0 0.0
Kidney disease (n = 5)
Stage 4 or 5 chronic kidney disease (eGFR < 30 ml/min)
with deteriorating health
3 60.0
Kidney failure complicating other life-limiting conditions
or treatments
3 60.0
Table 3 Prevalence of patients at risk of deteriorating and
dying (Continued)
n %
Stopping dialysis 0 0.0
Liver disease (n = 3)
Advanced cirrhosis with one or more complications
in the past year: diuretic-resistant ascites
0 0.0
Advanced cirrhosis with one or more complications
in the past year: hepatic encephalopathy
0 0.0
Advanced cirrhosis with one or more complications
in the past year: hepatorenal syndrome
0 0.0
Advanced cirrhosis with one or more complications
in the past year: bacterial peritonitis
0 0.0
Advanced cirrhosis with one or more complications
in the past year: recurrent variceal bleeds
0 0.0
Liver transplantation is contraindicated 2 66.7
Hamano et al. BMC Palliative Care           (2020) 19:32 Page 5 of 8
differences were observed in future inability to eat
(15.2% vs. 8.9%, p = 0.12). An optimized ACP discussion
on future ADL decline and surrogate decision makers
was significantly more frequent among patients at risk of
deteriorating and dying than among those not at risk
(10.6% vs. 2.5%, p = 0.007; 10.6% vs. 2.2%, p = 0.004).
Patients with PPS ≤ 70 (n = 80) discussed any ACP
topic significantly more often than those with PPS ≥ 80
(30.0% vs. 18.2%, p = 0.029), and had a significantly
higher frequency of the optimized ACP discussion
(20.0% vs. 2.3%, p < 0.001).
FP backgrounds and discussion of ACP
According to the univariate analysis, male sex (OR = 8.0,
95%CI 1.9–33.5, p = 0.001), clinical practice for ≥15 years
(OR = 2.1, 95%CI 1.3–3.4, p = 0.005), training in a pallia-
tive care unit (OR = 2.1, 95%CI 1.3–3.5, p = 0.005), and
participation in the nationwide palliative care education
program (OR = 2.1, 95%CI 1.0–4.3, p = 0.044) correlated
with the discussion of ACP topics. The multivariate ana-
lysis confirmed that male sex (OR = 6.6, 95%CI 1.5–29.3,
p = 0.012), clinical practice for ≥15 years (OR = 1.9,
95%CI 1.1–3.3, p = 0.021), and training in a palliative
care unit (OR = 2.6, 95%CI 1.4–4.6, p = 0.002) correlated
with the discussion of ACP topics (Additional file 4).
Discussion
To the best of our knowledge, this is the first large-scale
cross-sectional survey on the frequency of discussing ACP
and the topics involved among primary care outpatients,
their family members, and FPs. The first important result
was that 20.7% of primary care outpatients aged > 65 years
had discussed at least one ACP topic with their FPs. How-
ever, only 6% of patients had discussed at least one topic
with their family members and FPs with documentation
of the discussion in their medical records.
Since the frequency of discussing ACP depends on pa-
tient background factors and the definition of the discus-
sion, a systematic review revealed that its frequency
among frail elderly patients ranged widely between 2
and 29% [13]. When limited to studies with a similar pa-
tient background and definition of discussing ACP, the
present results were consistent with a multicenter cross-
sectional study on primary care outpatients in Japan, in
which the frequency of discussing ACP was 16.2% [17].
Therefore, approximately one fifth of primary care out-
patients may participate in ACP discussions on future
health care or surrogate decision makers with their FPs.
It is difficult to judge whether this represents an appro-
priate discussion of ACP because the quality of end-of-
life care was not assessed in the present study.
ACP discussions among patients, family members, and
FPs with documentation in medical records, which we de-
fined as an optimized ACP discussion, have not yet been
examined. Considering the purpose of discussing ACP, it
appears to be important to perform the optimized discus-
sion in order to improve the quality of end-of-life care.
We found that only 6.0% of patients had the optimized
ACP discussion, suggesting effective ACP discussion pro-
cesses have not yet been implemented in primary care.
The second important result of the present study was
that almost one fifth of patients had discussed future
ADL decline with their FPs. Although few studies have
investigated the frequency of ACP discussion topics in
the primary care setting, this result is similar to a previ-
ous finding showing that only 17% of community dwell-
ing persons older than 80 years had discussed their
wishes for end-of-life care with a physician or health
care provider [20].
On the other hand, 42% of patients with mild dementia
discussed illness-related topics, while 34% discussed prefer-
ences for medical treatment with their FPs during the last
3months of life [11]. This difference from the present re-
sults may be attributed to the frequency of discussing ACP
increasing with the risk of deteriorating and dying because
a previous study using hypothetical vignette scenarios re-
vealed that FPs identified patients with severe clinical mani-
festations as needing the ACP discussion [10].
The third important result was that the discussion of
ACP topics was significantly more frequent among pa-
tients at risk of deteriorating and dying than among
those who were not at risk. This result is consistent with
the study based on hypothetical vignette scenarios,
which revealed that FPs were more likely to discuss ACP
with patients showing severe clinical features [10]. Since
the SPICT-JP was not assessed in the present study, our
results may reflect the opinions of FPs on the risk of de-
teriorating and dying for primary care outpatients.
It is important to note that patients with PPS ≤ 70 had a
significantly higher proportion of ACP discussions with
patient (p = 0.029). However, the proportion of discus-
sions with patients documented in medical records about
any one of the ACP topics was significantly lower in pa-
tients with PPS ≤ 70 (p = 0.025), whereas no significant
difference was observed among patients at risk of deterior-
ating and dying or not (p = 1.000). This result suggests
that FPs conduct an ACP discussion based on factors
other than a poor performance status, such as a patient or
family member asking for palliative care, treatment with-
drawal/limitation, or a focus on quality of life.
The fourth important result was that male FPs with
long clinical experience and training at palliative care
units were more proactive about discussing ACP; how-
ever, the present results were not adjusted for variables
such as the perception of ACP and end-of-life care. This
result is consistent with the findings of a systematic re-
view, which indicated that accumulated skills facilitate
the engagement of FPs in ACP discussions [29]. While
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the present study suggested that male FPs were more
frequently involved in ACP discussions, Fulmer et al. re-
ported that female physicians were more likely to have
these discussions [30]. This difference may have arisen
because Fulmer’s study included physicians from several
specialties working in the hospital setting as well as FPs.
Thus, further studies are needed to investigate the back-
ground factors of FPs that influence discussions of ACP
in the primary care setting.
The present study had several limitations. We targeted a
very small proportion of certified FPs in Japan by purposive
sampling; therefore, the results obtained may not be repre-
sentative and their interpretation requires caution. Further-
more, the present results may have been influenced by the
Japanese health care system and cultural background;
therefore, difficulties are associated with generalizing these
results to other countries. In addition, observer recall bias
may have influenced the data obtained because difficulties
are associated with ascertaining whether undocumented
ACP discussions occurred. A gap may exist in the percep-
tion of the ACP discussion between FPs and their patients.
Another limitation is that there is currently no consensus
that the three ACP discussion topics defined in the present
study are standard evaluation items of the ACP process and
outcomes. Therefore, caution is required when assessing
the ACP process and outcomes performed by FPs based on
the results of this study.
Conclusion
FPs may only discuss ACP with a few of their patients;
however, this discussion may be more frequent with
patients who are at risk of deteriorating and dying. The
topic of future ADL decline was discussed and docu-
mented more often than other topics. However, FPs may
not document the results of most ACP discussions in
medical records. Further investigations are needed to es-
tablish whether the discussion of ACP between patients
and FPs improves the quality of end-of-life care.
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